Gutron (Midodrine Hydrochloride)

Gutron is indicated for the treatment of orthostatic hypotension, a condition characterized by a significant drop in blood pressure upon standing.

• Increases standing systolic blood pressure to reduce dizziness or fainting.
• Improves cerebral perfusion in patients experiencing postural drops in pressure.
• May be used as adjunct therapy when non‑pharmacologic measures are insufficient.
• Supports daily activities by stabilizing blood pressure during positional changes.
• Can be considered in patients with chronic autonomic failure causing hypotension.

Side effects of Gutron vary in frequency and severity; they stem from its vasoconstrictive action. Patients should be aware of both mild and potentially serious reactions.

Common

• Piloerection (goose‑flesh) and a feeling of cold in the limbs.
• Tingling or numbness in the hands and feet after dosing.
• Increased urinary urgency or frequency without pain.
• Pressure‑type headache that may worsen on standing.
• Transient flushing or skin redness within an hour of taking the drug.

Serious

• Supine hypertension, a rise in blood pressure while lying down, possibly requiring dose change.
• Severe hypertension presenting with chest pain, visual changes, or acute neurological symptoms.
• Reflex bradycardia that can cause dizziness or fainting in vulnerable patients.

When prescribing Gutron, clinicians should consider several precautions to ensure safe use and to minimize risk.

• Avoid use in patients with severe supine hypertension or uncontrolled hypertension.
• Monitor blood pressure regularly, especially after dose changes or when changing posture.
• Use caution in individuals with cardiovascular disease, such as ischemic heart disease or heart failure.
• Assess renal and hepatic function before initiating therapy, adjusting dose if impairment is present.
• Counsel patients to avoid lying flat for extended periods after taking the medication.
• Discontinue or reduce dose if symptoms of supine hypertension develop.

Gutron may interact with other medicines; understanding these interactions helps prevent adverse effects or reduced efficacy.

Avoid

• Monoamine oxidase inhibitors (MAOIs) – risk of hypertensive crisis.
• Direct vasoconstrictors such as epinephrine – additive increase in blood pressure.
• Tricyclic antidepressants – may potentiate pressor effects.
• Selective serotonin reuptake inhibitors (SSRIs) – may increase risk of hypertension.

Use with caution

• Diuretics – may enhance orthostatic hypotension when combined.
• Beta‑blockers – could mask reflex tachycardia associated with blood pressure changes.
• Calcium channel blockers – may blunt the pressor response.
• Other antihypertensive agents – require careful blood pressure monitoring.